Page 34 - IMCJ19s1

349. Yin H, Guo Q, Li X, Tang T, Li C, Wang H, et al. Curcumin Suppresses IL-1β Secretion and 382. Ross AC, Cousins RJ, Caballero B, et.al. Modern Nutrition in Health and Disease, 11th
Prevents Inflammation through Inhibition of the NLRP3 Inflammasome. J Immunol. 2018 edition. Chapter 52: Nutrition in Pregnancy. Wolters Kluwer Health, Lippincott Williams &
Apr 15;200(8):2835-2846. Wilkins. 2014
350. Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto, S. Potential Inhibitor of 383. Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by
COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular vitamin D. J Autoimmun. 2017 Dec;85:78-97.
Docking Study. Preprints 2020, 2020030226.
351. Utomo RY, Ikawati M, Meiyanto E. Revealing the Potency of Citrus and Galangal
Constituents to Halt SARS-CoV-2 Infection. Preprints 2020, 2020030214.
352. Secor ER Jr, Carson WF IV, Cloutier MM, et al. Bromelain exerts anti-inflammatory effects
in an ovalbumin-induced murine model of allergic airway disease. Cell Immunol (2005)
237 68–75.
353. Rimoldi R, Ginesu F, Giura R. The use of bromelain in pneumological therapy. Drugs Exp
Clin Res (1978) 4 55–66.
354. Müller S, März R, Schmolz M, Drewelow B, Eschmann K, Meiser P. Placebo-controlled
randomized clinical trial on the immunomodulating activities of low- and high-dose
bromelain after oral administration - new evidence on the antiinflammatory mode of
action of bromelain. Phytother Res. 2013 Feb;27(2):199-204.
355. Shabani M, Sadeghi A, Hosseini H, Teimouri M, Babaei Khorzoughi R, Pasalar P, Meshkani
R. Resveratrol alleviates obesity-induced skeletal muscle inflammation via decreasing M1
macrophage polarization and increasing the regulatory T cell population. Sci Rep. 2020
Mar 2;10(1):3791.
356. Sarubbo F, Esteban S, Miralles A, Moranta D. Effects of Resveratrol and other Polyphenols
on Sirt1: Relevance to Brain Function During Aging. Curr Neuropharmacol. 2018 Jan
30;16(2):126-136.
357. Pan W, Yu H, Huang S, Zhu P. Resveratrol Protects against TNF-α-Induced Injury in
Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of
NF-KB and p38 MAPK. PLoS One. 2016 Jan 22;11(1):e0147034.
358. Chen LZ, Yao L, Jiao MM, Shi JB, Tan Y, Ruan BF, Liu XH. Novel resveratrol-based flavonol
derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo. Eur J Med Chem.
2019 Aug 1;175:114-128.
359. Misawa T, Saitoh T, Akira S. Resveratrol inhibits the acetylated α-tubulin-mediated
assembly of the NLRP3-inflammasome. Int Immunol. 2015 Sep;27(9):425-34.
360. Peredo-Escárcega AE, Rubio-Ruiz ME, et al. The Combination of Resveratrol and
Quercetin Attenuates Metabolic Syndrome in Rats by Modifying the Serum Fatty Acid
Composition and by Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue.
Evid Based Complement Alternat Med. 2015;2015:474032.
361. Yang SJ, Lim Y. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3
inflammasome activation. Metabolism. 2014 May;63(5):693-701.
362. Li YQ, Li ZL, Zhao WJ, Wen RX, Meng QW, Zeng Y. Synthesis of stilbene derivatives with
inhibition of SARS coronavirus replication. Eur J Med Chem. 2006 Sep;41(9):1084-9. Epub
2006 Jul 27.
363. Kode A, Rajendrasozhan S, Caito S, et al. Resveratrol induces glutathione synthesis by
activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human
lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008 Mar;294(3):L478-88.
364. Bonnefont-Rousselot D. Resveratrol and Cardiovascular Diseases. Nutrients. 2016 May
2;8(5). pii: E250.
365. Chaplin A, Carpéné C, Mercader J. Resveratrol, Metabolic Syndrome, and Gut Microbiota.
Nutrients. 2018 Nov 3;10(11). pii: E1651.
366. Ali, E.N., Mansour, S.Z. Boswellic acids extract attenuates pulmonary fibrosis induced by
bleomycin and oxidative stress from gamma irradiation in rats. Chin Med 6, 36 (2011).
367. Siemoneit U, Hofmann B, Kather N, et al: Identification and functional analysis of
cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol 75:503-513,
2008.
368. Wang H, Syrovets T, Kess D, et al: Targeting NF-kappa B with a natural triterpenoid
alleviates skin inflammation in a mouse model of psoriasis. J Immunol 183:4755-4763,
2009.
369. Li S, Yang H, Chen X. Protective effects of sulforaphane on diabetic retinopathy: activation
of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation. Exp Anim. 2019
May 8;68(2):221-231.
370. Yang G, Yeon SH, Lee HE, Kang HC, Cho YY, Lee HS, Lee JY. Suppression of NLRP3
inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.
Rheumatology (Oxford). 2018 Apr 1;57(4):727-736.
371. Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH. Sulforaphane attenuates
pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. BMC Pharmacol
Toxicol. 2018 Apr 2;19(1):13.
372. Sedlak TW, Nucifora LG, Koga M, Shaffer LS, Higgs C, Tanaka T. Sulforaphane Augments
Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study.
Mol Neuropsychiatry. 2018 May;3(4):214-222.
373. Dias IH, Chapple IL, Milward M, Grant MM, Hill E, Brown J, Griffiths HR. Sulforaphane
restores cellular glutathione levels and reduces chronic periodontitis neutrophil
hyperactivity in vitro. PLoS One. 2013 Jun 24;8(6):e66407.
374. Kim I, He YY. Targeting the AMP-Activated Protein Kinase for Cancer Prevention and
Therapy. Front Oncol. 2013 Jul 15;3:175.
375. Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L, Sergio F. N-Acetylcysteine
as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 2018
Jul;52(7):751-762.
376. Ansari SF, Memon M, Brohi N, Tahir A. N-acetylcysteine in the Management of Acute
Exacerbation of Chronic Obstructive Pulmonary Disease. Cureus, 11 (11), e6073 2019 Nov
5.
377. Masoompour SM, Anushiravani A, Tafaroj Norouz A. Evaluation of the Effect of Nebulized
N-Acetylcysteine on Respiratory Secretions in Mechanically Ventilated Patients:
Randomized Clinical Trial. Iran J Med Sci. 2015 Jul;40(4):309-15.
378. Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, et al. The Role of
glutathione-S-transferase Polymorphisms on Clinical Outcome of ALI/ARDS Patient
Treated With N-acetylcysteine. Respir Med Actions, 103 (3), 434-41.
379. Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D. Randomized, double-blind, pilot
evaluation of intravenous glutathione in Parkinson’s disease. Mov Disord. 2009 May
15;24(7):979-83.
380. Calabrese C, Tosco A, Abete P, Carnovale V, Basile C, et al. Randomized, single blind,
controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis. J Cyst
Fibros. 2015 Mar;14(2):203-10.
381. Bagnato GF, Gulli S, De Pasquale R, Giacobbe O, Spatari G, Purello D’Ambrosio F. Effect
of inhaled glutathione on airway response to ‘Fog’ challenge in asthmatic patients.
Respiration. 1999 Nov-Dec;66(6):518-21.
32 Integrative Medicine • Vol. 19, No. S1 • Epub Ahead of Print Yanuck—Immuno-physiological Approach to COVID-19